These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7710635)

  • 1. Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin.
    Bourdouxhe C; Colson P; Houssier C; Hénichart JP; Waring MJ; Denny WA; Bailly C
    Anticancer Drug Des; 1995 Mar; 10(2):131-54. PubMed ID: 7710635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin.
    Bourdouxhe-Housiaux C; Colson P; Houssier C; Waring MJ; Bailly C
    Biochemistry; 1996 Apr; 35(14):4251-64. PubMed ID: 8605173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate.
    Boitte N; Pommery N; Colson P; Houssier C; Waring MJ; Hénichart JP; Bailly C
    Anticancer Drug Des; 1997 Sep; 12(6):481-501. PubMed ID: 9311557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA.
    Plouvier B; Houssin R; Helbecque N; Colson P; Houssier C; Hénichart JP; Bailly C
    Anticancer Drug Des; 1995 Mar; 10(2):155-66. PubMed ID: 7710636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of electric linear dichroism and competition experiments with intercalating drugs to investigate the mode of binding of Hoechst 33258, berenil and DAPI to GC sequences.
    Colson P; Houssier C; Bailly C
    J Biomol Struct Dyn; 1995 Oct; 13(2):351-66. PubMed ID: 8579793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
    Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C
    Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
    Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
    Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of DNA-threading peptide-amsacrine conjugates with DNA and chromatin.
    Bourdouxhe-Housiaux C; Colson P; Houssier C; Bailly C
    Anticancer Drug Des; 1996 Oct; 11(7):509-25. PubMed ID: 8921934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding properties and DNA sequence-specific recognition of two bithiazole-linked netropsin hybrid molecules.
    Bailly C; Colson P; Houssier C; Houssin R; Mrani D; Gosselin G; Imbach JL; Waring MJ; Lown JW; Hénichart JP
    Biochemistry; 1992 Sep; 31(35):8349-62. PubMed ID: 1381962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
    Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
    Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and sequence-specific analysis of DNA-ligand interaction by means of fluorescent intercalator probes.
    Kirschstein O; Sip M; Kittler L
    J Mol Recognit; 2000; 13(3):157-63. PubMed ID: 10867711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic studies of 9-hydroxyellipticine binding to DNA.
    Ismail MA; Sanders KJ; Fennell GC; Latham HC; Wormell P; Rodger A
    Biopolymers; 1998 Sep; 46(3):127-43. PubMed ID: 9741963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition.
    Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV
    J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand.
    Bailly C; Helbecque N; Hénichart JP; Colson P; Houssier C; Rao KE; Shea RG; Lown JW
    J Mol Recognit; 1990 Feb; 3(1):26-35. PubMed ID: 2354061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies.
    Lee M; Krowicki K; Shea RG; Lown JW; Pon RT
    J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
    Xie G; Gupta R; Lown JW
    Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA intramolecular triplexes containing dT --> dU substitutions: unfolding energetics and ligand binding.
    Soto AM; Rentzeperis D; Shikiya R; Alonso M; Marky LA
    Biochemistry; 2006 Mar; 45(9):3051-9. PubMed ID: 16503660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the DNA binding modes of a topoisomerase I-poisoning terbenzimidazole: evidence for both intercalative and minor groove binding properties.
    Pilch DS; Xu Z; Sun Q; Lavoie EJ; Liu LF; Geacintov NE; Breslauer KJ
    Drug Des Discov; 1996 Apr; 13(3-4):115-33. PubMed ID: 8874049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the nonintercalative antitumour drugs SN-6999 and SN-18071 with DNA: influence of ligand structure on the binding specificity.
    Luck G; Reinert KE; Baguley B; Zimmer C
    J Biomol Struct Dyn; 1987 Jun; 4(6):1079-94. PubMed ID: 2855925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.